A 52-year-old woman with T2DM and obesity (BMI 36) on metformin and SGLT2 inhibitor has A1C 7.9% and established ASCVD. Best next glucose-lowering age...

Question

A 52-year-old woman with T2DM and obesity (BMI 36) on metformin and SGLT2 inhibitor has A1C 7.9% and established ASCVD. Best next glucose-lowering agent to reduce CV events?

Accepted Answer

GLP-1 receptor agonist with CV benefit

Answer

DPP-4 inhibitor

Answer

Basal insulin

Answer

Sulfonylurea

Answer

Alpha-glucosidase inhibitor

us-usmle-step-2 MCQ (SBA): Type 2 Diabetes-ASCVD

A 52-year-old woman with T2DM and obesity (BMI 36) on metformin and SGLT2 inhibitor has A1C 7.9% and established ASCVD. Best next glucose-lowering agent to reduce CV events?